The treatment will be rolled out to those who have already suffered a heart attack or stroke.
A cholesterol-lowering drug that could save tens of thousands of lives over the next decade will be offered to people on the NHS.
Inclisiran, described as a “game-changer”, is hoped to prevent thousands of heart attacks and strokes, in the coming years.
It will be rolled out to hundreds of thousands of people with high cholesterol or mixed dyslipidemia – abnormally high levels of fats in their blood – who have already suffered a heart attack or stroke.
The initial dose of the drug will be administered via an injection in GP surgeries across England, followed by another three months later, and then twice a year thereafter.
Inclisiran is the first of a new type of cholesterol-lowering treatment RNA interference to help the liver remove harmful cholesterol from the blood.